CR Medicon signed strategic partnership agreements with Sun Technology Cloud and Pharmaron. We are integrating Sun Tech Cloud’s eCTD submission system, the first Chinese version developed domestically in China, to help Chinese and US clients accelerate development and registration of innovative drugs. Pharmaron’s business segments cover drug synthesis and screening, pre-clinical trials, etc. The introduction of Pharmaron as a partner will create a synergistic effect, forming a complete industry chain from early drug discovery to drug registration and commercialization. CR Medicon is having long-term and in-depth collaborations with these two well-known companies in drug discovery, preclinical experiments, clinical trials, drug registration, eCTD submission, etc. By working together, we’ll jointly promote pragmatic cooperations in the field of new drug research and development, and achieve synergy and win-win; This partnership also saves clients energy and time in finding service partners for different projects and phases, which in turn promotes more efficient use of resources achieving cost savings, streamlined communications, and resource integration.